Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single vs Multiple Dose Antibiotics for Elective Cesarean Section Prophylaxis
NCT02736682Phase 4Completed
- Sponsor
- Makerere University
- Start
- Sep 2015
- Primary completion
- Feb 2016
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of ceftriaxone, metronidazole in post-operative infection, sponsored by Makerere University. Started Sep 2015; status: completed.
02
Drugs
ceftriaxonemetronidazole
03
Conditions
post-operative infection
Beyond the preview
Go deeper on NCT02736682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02736682.